Prendingue, Mansueto D.

HRN: 26-46-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2025
MUPIROCIN 2%, 15G (TUBE)
01/25/2025
02/01/2025
TOPICAL
Apply On Affected Are
BID
Decubitus Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: